Azintuxizumab
Modify Date: 2025-08-25 20:33:53
Azintuxizumab structure
|
Common Name | Azintuxizumab | ||
|---|---|---|---|---|
| CAS Number | 1826819-57-1 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of AzintuxizumabAzintuxizumab (ABBV-383; PR-1471272) is a SLAMF7 targeting antibody-drug conjugate (ADC). Azintuxizumab consists of a SLAMF7-targeted mAb and a monomethyl auristatin E (MMAE) via a cathepsin B-cleavable peptide linker. Azintuxizumab has the potential for the research of multiple myeloma[1]. |
| Name | Azintuxizumab |
|---|
| Description | Azintuxizumab (ABBV-383; PR-1471272) is a SLAMF7 targeting antibody-drug conjugate (ADC). Azintuxizumab consists of a SLAMF7-targeted mAb and a monomethyl auristatin E (MMAE) via a cathepsin B-cleavable peptide linker. Azintuxizumab has the potential for the research of multiple myeloma[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |